Zobrazeno 1 - 10
of 66
pro vyhledávání: '"N. Thiruthaneeswaran"'
Publikováno v:
Technical Innovations & Patient Support in Radiation Oncology, Vol 16, Iss , Pp 39-47 (2020)
Cancer is predominantly a disease of the elderly and as population life expectancy increases, so will the incidence of malignant disease. Elderly patients often have other comorbidities and social complexities, increasing the support required to safe
Externí odkaz:
https://doaj.org/article/47e598f82a644a4a8af3e5661305051c
Autor:
Adèle C. Green, N. Thiruthaneeswaran, Catharine M L West, B. Lane, R. Rodrigues Pereira, Ananya Choudhury, Peter Hoskin, M. van Herk, Jane Shortall, B. Bibby, T. Elumalai, E. Vasquez Osorio, Alan McWilliam
Publikováno v:
Radiotherapy and Oncology. 161:S504-S506
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8007fb1a79560158925c6aa83594746a
https://doi.org/10.1016/s0167-8140(21)06995-4
https://doi.org/10.1016/s0167-8140(21)06995-4
Autor:
Becky A.S. Bibby, Ronnie Rodrigues Pereira, Ananya Choudhury, Kaye J. Williams, Elisabet More, Darragh G. McArt, Robert G. Bristow, Paul G. O’Reilly, N. Thiruthaneeswaran, Catharine M L West, Lingjian Yang
Publikováno v:
Bibby, B A S, Thiruthaneeswaran, N, Yang, L, Pereira, R R, More, E, McArt, D G, O'Reilly, P, Bristow, R G, Williams, K J, Choudhury, A & West, C M L 2021, ' Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer ', BMC urology, vol. 21, no. 1, 96 . https://doi.org/10.1186/s12894-021-00856-x
BMC Urology
Bibby, B A S, Thiruthaneeswaran, N, Yang, L, Pereira, R R, More, E, McArt, D G, O'Reilly, P, Bristow, R G, Williams, K J, Choudhury, A & West, C M L 2021, ' Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer ', BMC Urology, vol. 21, no. 1, pp. 96 . https://doi.org/10.1186/s12894-021-00856-x
BMC Urology, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Urology
Bibby, B A S, Thiruthaneeswaran, N, Yang, L, Pereira, R R, More, E, McArt, D G, O'Reilly, P, Bristow, R G, Williams, K J, Choudhury, A & West, C M L 2021, ' Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer ', BMC Urology, vol. 21, no. 1, pp. 96 . https://doi.org/10.1186/s12894-021-00856-x
BMC Urology, Vol 21, Iss 1, Pp 1-11 (2021)
Background The presence of hypoxia is a poor prognostic factor in prostate cancer and the hypoxic tumor microenvironment promotes radioresistance. There is potential for drug radiotherapy combinations to improve the therapeutic ratio. We aimed to inv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::96352efa42d651655e10ac31beee7b74
https://pure.manchester.ac.uk/ws/files/196449568/s12894_021_00856_x.pdf
https://pure.manchester.ac.uk/ws/files/196449568/s12894_021_00856_x.pdf
Autor:
N. Thiruthaneeswaran, Catharine M L West, Lingjang Yang, Robert G. Bristow, B. Bibby, Peter Hoskin, Ananya Choudhury
Publikováno v:
Thiruthaneeswaran, N, Bibby, B A S, Yang, L, Hoskin, P J, Bristow, R G, Choudhury, A & West, C 2021, ' Lost in application : Measuring hypoxia for radiotherapy optimisation ', European journal of cancer (Oxford, England : 1990), vol. 148, pp. 260-276 . https://doi.org/10.1016/j.ejca.2021.01.039
The history of radiotherapy is intertwined with research on hypoxia. There is level 1a evidence that giving hypoxia-targeting treatments with radiotherapy improves locoregional control and survival without compromising late side-effects. Despite comi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5c2893a1a65026ea816a507c1b6244
https://pubmed.ncbi.nlm.nih.gov/33756422
https://pubmed.ncbi.nlm.nih.gov/33756422
Publikováno v:
Clinical Oncology
Clinical Oncology (Royal College of Radiologists (Great Britain)
Clinical Oncology (Royal College of Radiologists (Great Britain)
The novel coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has had a devastating impact, with the number of deaths worldwide by June 2020 over 400 000. There are currently no proven, effec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23cd81903a9efb87144df5dd5842dde1
https://hdl.handle.net/2123/22589
https://hdl.handle.net/2123/22589
Publikováno v:
Brachytherapy. 17:181-186
Purpose Image-guided plan optimization with MRI and CT for interstitial and intracavitary brachytherapy is an established technique in treating cervical cancer. The purpose of this study was to assess the feasibility of boosting the dose to the resid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4488cdb7f387a21b5a23bff66233379a
https://doi.org/10.1016/j.brachy.2017.09.012
https://doi.org/10.1016/j.brachy.2017.09.012
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Richard Simcock, Sandra Turner, A. O'Donovan, A. Cree, Meera Agar, Lucinda Morris, N. Thiruthaneeswaran
Publikováno v:
Radiotherapy and Oncology. 152:S665-S666
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12b1dbe8ee74b23ca0373de3f49efe84
https://doi.org/10.1016/s0167-8140(21)01281-0
https://doi.org/10.1016/s0167-8140(21)01281-0
Autor:
N. Thiruthaneeswaran, Catharine M L West, Robert G. Bristow, Elisabet More, Ananya Choudhury, Becky A.S. Bibby, Ronnie Rodrigues Pereira
Publikováno v:
Radiotherapy and Oncology. 152:S167-S168
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9fe8f56f34f70b40207fe20b7fcdc569
https://doi.org/10.1016/s0167-8140(21)00343-1
https://doi.org/10.1016/s0167-8140(21)00343-1